Trial Profile
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Therapeutic Exploratory Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 After Oral Administration in Male Patients With Premature Ejaculation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs DA 8031 (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 28 Feb 2013 New trial record